UB Paderborn / Katalog / Suche / in CDI

6ER-001 The use of gamification to evaluate public understanding of adverse drug reactions

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A161-A161

Lin, YN

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-025 Effectiveness and safety of 20% autologous serum eye drops in patients with corneal surface pathologies

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A167-A167

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-018 Use of eltrombopag in routine clinical practice

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A172-A172

2022

Link zum Volltext

Verfügbarkeit prüfen

6ER-012 Effectiveness of IL-23 inhibitors in patients with moderate–severe chronic plaque psoriasis

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A171-A171

2022

Link zum Volltext

Verfügbarkeit prüfen

6ER-024 Potentially drug-related problems in a polymedicated population

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A175-A175

2022

Link zum Volltext

Verfügbarkeit prüfen

6ER-021 Retrospective of drug innovation during the SARS-Cov2 pandemic: development of a game-based training

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A165-A165

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-011 Efficacy of therapies in non-small-cell lung cancer with eGFR exon 20 insertion mutations: a systematic review

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A163-A164

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-033 Pembrolizumab and atezolizumab as possible equivalent first-line therapeutic alternatives in PD-L1-expressing triple-negative breast cancer

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A170-A170

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-024 Comparison of reductions in monthly migraine days between new small molecule cgrp receptor antagonists (gepants) and monoclonal antibodies targeting cgrp/cgrp receptor

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A166-A166

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-019 The student pharmacist experience of enhanced clinical placements

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A164-A165

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-034 Use of closed system transfer devices with investigational drug products

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A170-A171

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-020 Prescription and use of liposomal amphotericin b during the COVID-19 pandemic

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A165-A165

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-032 How can Dutch university hospitals contribute to affordable medicines and cost containment of total hospital drug expenditure: a Delphi study

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A169-A170

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-022 Clinical impact of the use of glucocorticoids for the treatment of COVID-19 in intermediate respiratory care units

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A165-A166

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-017 Structured objective clinical evaluation for pharmacy students on internships at the hospital

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A164-A164

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-029 Eye drops of interferon alpha-2b to treat ocular pathologies

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A168-A169

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-009 Comparative efficacy of abemaciclib and palbociclib as adjuvant treatment in patients with early breast cancer

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A162-A163

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-028 Market exclusivity expiry has limited effect on prices of brand-name orphan drugs

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A177-A177

2022

Link zum Volltext

Verfügbarkeit prüfen

6ER-014 Analysis of the evolution of interleukin-6 in COVID-19 patients after being treated with dexamethasone

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A171-A172

2022

Link zum Volltext

Verfügbarkeit prüfen

6ER-026 Effectiveness and safety of apremilast in a third-level hospital

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A176-A176

2022

Link zum Volltext

Verfügbarkeit prüfen

6ER-002 Applying reflective multicriteria decision analysis to understand the value of therapeutic alternatives in the management of anaemia in gynaecologic surgery

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A168-A169

2022

Link zum Volltext

Verfügbarkeit prüfen

6ER-021 Evaluation of COVID mortality during hospital admission in patients receiving oncological treatment

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A174-A174

2022

Link zum Volltext

Verfügbarkeit prüfen

6ER-005 Reducing invasive device-related bloodstream infections: a challenge for the prevention of healthcare-associated infections

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A169-A169

2022

Link zum Volltext

Verfügbarkeit prüfen

6ER-023 Study of the use of ceftazidima-avibactam in a third-level university hospital

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A175-A175

2022

Link zum Volltext

Verfügbarkeit prüfen

6ER-019 Determination of doxorubicin from the efluate of cells using the Druglog system

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A173-A173

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

6ER-001 The use of gamification to evaluate public understanding of adverse drug reactions

6ER-025 Effectiveness and safety of 20% autologous serum eye drops in patients with corneal surface pathologies

6ER-018 Use of eltrombopag in routine clinical practice

6ER-012 Effectiveness of IL-23 inhibitors in patients with moderate–severe chronic plaque psoriasis

6ER-024 Potentially drug-related problems in a polymedicated population

6ER-021 Retrospective of drug innovation during the SARS-Cov2 pandemic: development of a game-based training

6ER-011 Efficacy of therapies in non-small-cell lung cancer with eGFR exon 20 insertion mutations: a systematic review

6ER-033 Pembrolizumab and atezolizumab as possible equivalent first-line therapeutic alternatives in PD-L1-expressing triple-negative breast cancer

6ER-024 Comparison of reductions in monthly migraine days between new small molecule cgrp receptor antagonists (gepants) and monoclonal antibodies targeting cgrp/cgrp receptor

6ER-019 The student pharmacist experience of enhanced clinical placements

6ER-034 Use of closed system transfer devices with investigational drug products

6ER-020 Prescription and use of liposomal amphotericin b during the COVID-19 pandemic

6ER-032 How can Dutch university hospitals contribute to affordable medicines and cost containment of total hospital drug expenditure: a Delphi study

6ER-022 Clinical impact of the use of glucocorticoids for the treatment of COVID-19 in intermediate respiratory care units

6ER-017 Structured objective clinical evaluation for pharmacy students on internships at the hospital

6ER-029 Eye drops of interferon alpha-2b to treat ocular pathologies

6ER-009 Comparative efficacy of abemaciclib and palbociclib as adjuvant treatment in patients with early breast cancer

6ER-028 Market exclusivity expiry has limited effect on prices of brand-name orphan drugs

6ER-014 Analysis of the evolution of interleukin-6 in COVID-19 patients after being treated with dexamethasone

6ER-026 Effectiveness and safety of apremilast in a third-level hospital

6ER-002 Applying reflective multicriteria decision analysis to understand the value of therapeutic alternatives in the management of anaemia in gynaecologic surgery

6ER-021 Evaluation of COVID mortality during hospital admission in patients receiving oncological treatment

6ER-005 Reducing invasive device-related bloodstream infections: a challenge for the prevention of healthcare-associated infections

6ER-023 Study of the use of ceftazidima-avibactam in a third-level university hospital

6ER-019 Determination of doxorubicin from the efluate of cells using the Druglog system

Suchergebnisse filtern